Risk factors
CapsoVision (CV) risk factors
Item 1A of every CapsoVision, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors69 risks
CapsoVision faces substantial net losses of $25.3M in 2025 and going concern warnings from its auditors. The company relies heavily on single-source suppliers in Taiwan and Japan for its CapsoCam medical devices. Commercial growth depends on FDA clearances for CapsoCam Colon and proprietary AI diagnostic tools.
Filed Mar 26, 2026